Drugs Made In America Acquisition (DMII) EPS (Basic) (2025)
Drugs Made In America Acquisition (DMII) posted quarterly EPS (Basic) of $0.16 for Q4 2025, up 23901.67% quarter-over-quarter from -$0.0 in Q3 2025.
Drugs Made In America Acquisition (DMII) EPS (Basic) (2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has reported EPS (Basic) for 1 consecutive years, with $0.16 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 0.07 |
| 2 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 0.07 |
| 3 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - | 0.07 |
| 4 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 0.01 |
| 5 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 0.09 |
| 6 | Gores Holdings X | 381.05 Mn | 380.85 Mn | - | 0.05 |
| 7 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | - |
| 8 | Blue Water Acquisition Corp. III | 342.12 Mn | 342.08 Mn | - | -0.01 |
| 9 | Berto Acquisition | 313.96 Mn | 313.81 Mn | - | 0.03 |
| 10 | New Providence Acquisition Corp. III | 313.81 Mn | 313.81 Mn | - | 0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.00 |